UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 405

Sortiert nach

Risk factors for recurrence of ovarian borderline tumors

Gynecologic oncology, 2011-03, Vol.120 (3), p.480-484

2011

Volltextzugriff (PDF)

The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer

Annals of oncology, 2014-12, Vol.25 (12), p.2372-2378

2014

Volltextzugriff (PDF)

The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with advanced ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.103-103

2017

Volltextzugriff (PDF)

A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: Toward improving individualized cancer care

Gynecologic oncology, 2010-03, Vol.116 (3), p.399-403

2010

Volltextzugriff (PDF)

Comparison of outcomes in optimally-cytoreduced ovarian cancer patients receiving postoperative intraperitoneal chemotherapy vs intravenous dose-dense chemotherapy without bevacizumab

Gynecologic oncology, 2017-06, Vol.145, p.136-136

2017

Volltextzugriff (PDF)

Primary debulking surgery for advanced ovarian cancer: The Kaizen approach to continued improvement in surgical outcomes

Gynecologic oncology, 2017-06, Vol.145, p.197-198

2017

Volltextzugriff (PDF)

Incidence of surgical site infection after implementation of a reduction bundle in gynecologic cancer patients undergoing colon surgery at a comprehensive cancer center

Gynecologic oncology, 2017-06, Vol.145, p.13-14

2017

Volltextzugriff (PDF)

Surgery at a high-volume center reduces the impact of income on survival for women with advanced ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.149-149

2017

Volltextzugriff (PDF)

THE PI3Kδ INHIBITOR ME‐401 ± RITUXIMAB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL)

Hematological oncology, 2019-06, Vol.37 (S2), p.176-177

2019

Volltextzugriff (PDF)

Interval cytoreductive surgical outcome following administration of standard versus dose-dense neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer

Gynecologic oncology, 2016-06, Vol.141, p.160-160

2016

Volltextzugriff (PDF)

Intraperitoneal chemotherapy outcomes following interval cytoreductive surgery for advanced-stage ovarian cancer at a comprehensive cancer center

Gynecologic oncology, 2016-06, Vol.141, p.29-29

2016

Volltextzugriff (PDF)

A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery

Gynecologic oncology, 2016-06, Vol.141, p.162-162

2016

Volltextzugriff (PDF)

Recurrent ovarian cancer: Can second clinical remission surpass the first?

Gynecologic oncology, 2016-06, Vol.141, p.174-175

2016

Volltextzugriff (PDF)

Survival in patients with uterine carcinosarcoma undergoing sentinel lymph node mapping

Gynecologic oncology, 2015-04, Vol.137, p.199-199

2015

Volltextzugriff (PDF)

Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer

Gynecologic oncology, 2014-06, Vol.133, p.97-98

2014

Volltextzugriff (PDF)

Uterine washing biomarkers as a novel screening tool for high-grade serous carcinoma

Gynecologic oncology, 2013-07, Vol.130 (1), p.e71-e71

2013

Volltextzugriff (PDF)

Redefining stage I endometrial cancer: Incorporating histology, grade, myoinvasion, and whether or not lymph nodes were removed

Gynecologic oncology, 2013-07, Vol.130 (1), p.e74-e74

2013

Volltextzugriff (PDF)

Does para-aortic lymph node assessment during endometrial cancer staging impact overall survival?

Gynecologic oncology, 2013-07, Vol.130 (1), p.e73-e74

2013

Volltextzugriff (PDF)

Handbook of Methods for Designing, Monitoring, and Analyzing Dose-Finding Trials

1, 2017

Volltextzugriff (PDF)

Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer

Gynecologic oncology, 2007-10, Vol.107 (1), p.66-70

2007

Volltextzugriff (PDF)

The changing clinical features of cervical adenocarcinoma: Increasing proportion but favorable oncologic outcome

Gynecologic oncology, 2012-03, Vol.125, p.S60-S60

2012

Volltextzugriff (PDF)

Outcomes of surgery for stage IB cervical cancer: Variations between squamous and adenocarcinoma histology

Gynecologic oncology, 2011-03, Vol.120, p.S111-S111

2011

Volltextzugriff (PDF)

Postoperative delirium in older patients with cancer undergoing major surgery

Journal of geriatric oncology, 2013-10, Vol.4, p.S70-S71

2013

Volltextzugriff (PDF)

Does operative start time impact the frequency of complete gross resection in patients undergoing primary cytoreduction for advanced serous ovarian carcinoma?

Gynecologic oncology, 2011-05, Vol.121 (2), p.S2-S2

2011

Volltextzugriff (PDF)

Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent high-grade and low-grade serous ovarian cancer

Gynecologic oncology, 2020-10, Vol.159, p.23-23

2020

Volltextzugriff (PDF)

1 – 25 von 405

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(383)
Mit Volltextzugriff
(346)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(227)
Life Sciences & Biomedicine
(219)
Humans
(196)
Oncology
(190)
Female
(156)
Middle Aged
(116)
Aged
(109)
Obstetrics & Gynecology
(106)
Adult
(105)
Ovarian Cancer
(78)
Aged, 80 And Over
(64)
Retrospective Studies
(59)
Hematology, Oncology And Palliative Medicine
(52)
Neoplasm Staging
(50)
Obstetrics And Gynecology
(49)
Tumors
(38)
Ovarian Neoplasms - Drug Therapy
(37)
Ovarian Neoplasms - Pathology
(37)
Endometrial Cancer
(36)
Chemotherapy
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Risk factors for recurrence of ovarian borderline tumors

The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer

The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with advanced ovarian cancer

A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: Toward improving individualized cancer care

Comparison of outcomes in optimally-cytoreduced ovarian cancer patients receiving postoperative intraperitoneal chemotherapy vs intravenous dose-dense chemotherapy without bevacizumab

Primary debulking surgery for advanced ovarian cancer: The Kaizen approach to continued improvement in surgical outcomes

Incidence of surgical site infection after implementation of a reduction bundle in gynecologic cancer patients undergoing colon surgery at a comprehensive cancer center

Surgery at a high-volume center reduces the impact of income on survival for women with advanced ovarian cancer

THE PI3Kδ INHIBITOR ME‐401 ± RITUXIMAB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL)

Interval cytoreductive surgical outcome following administration of standard versus dose-dense neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer

Intraperitoneal chemotherapy outcomes following interval cytoreductive surgery for advanced-stage ovarian cancer at a comprehensive cancer center

A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery

Recurrent ovarian cancer: Can second clinical remission surpass the first?

Survival in patients with uterine carcinosarcoma undergoing sentinel lymph node mapping

Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer

Uterine washing biomarkers as a novel screening tool for high-grade serous carcinoma

Redefining stage I endometrial cancer: Incorporating histology, grade, myoinvasion, and whether or not lymph nodes were removed

Does para-aortic lymph node assessment during endometrial cancer staging impact overall survival?

Handbook of Methods for Designing, Monitoring, and Analyzing Dose-Finding Trials

Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer

The changing clinical features of cervical adenocarcinoma: Increasing proportion but favorable oncologic outcome

Outcomes of surgery for stage IB cervical cancer: Variations between squamous and adenocarcinoma histology

Postoperative delirium in older patients with cancer undergoing major surgery

Does operative start time impact the frequency of complete gross resection in patients undergoing primary cytoreduction for advanced serous ovarian carcinoma?

Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent high-grade and low-grade serous ovarian cancer

Suchergebnisse filtern